Agios Pharmaceuticals, Inc. (AGIO)
27.71
+0.58
(+2.14%)
USD |
NASDAQ |
Feb 11, 16:00
28.00
+0.29
(+1.05%)
After-Hours: 07:57
Agios Pharmaceuticals Total Assets (Quarterly) : 1.386B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | -- |
| CorMedix, Inc. | 750.86M |
| Gilead Sciences, Inc. | 59.02B |
| Fulcrum Therapeutics, Inc. | 214.86M |
| Moderna, Inc. | 12.14B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 101.38M |
| Shareholders Equity (Quarterly) | 1.284B |
| Debt to Equity Ratio | 0.0347 |
| Current Ratio | 13.82 |
| Net Debt Paydown Yield | 0.17% |